Therapy for haemophilia: recent advances and goals for the future.
about
In vivo models of haemophilia - status on current knowledge of clinical phenotypes and therapeutic interventions.Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography.A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors.Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.Bypass therapy assay testing as a strategy to reduce costs for treatment of haemophilia patients with inhibitors.
P2860
Therapy for haemophilia: recent advances and goals for the future.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Therapy for haemophilia: recent advances and goals for the future.
@ast
Therapy for haemophilia: recent advances and goals for the future.
@en
type
label
Therapy for haemophilia: recent advances and goals for the future.
@ast
Therapy for haemophilia: recent advances and goals for the future.
@en
prefLabel
Therapy for haemophilia: recent advances and goals for the future.
@ast
Therapy for haemophilia: recent advances and goals for the future.
@en
P2860
P1476
Therapy for haemophilia: recent advances and goals for the future.
@en
P2093
Louis Aledort
P2860
P304
P356
10.1517/14728214.10.1.173
P407
P577
2005-02-01T00:00:00Z